Wafra Inc. Elanco Animal Health Inc Transaction History

Wafra Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$28.76 - $35.98 $20.2 Million - $25.2 Million	-701,127 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$27.85 - $34.49 $21.1 Million - $26.1 Million	-757,756 Reduced 51.94%	701,127 $20.6 Million
Q4 2020 Feb 11, 2021	BUY	$27.53 - $33.79 $8.58 Million - $10.5 Million	311,572 Added 27.16%	1,458,883 $44.7 Million
Q3 2020 Nov 12, 2020	BUY	$21.1 - $29.13 $4.84 Million - $6.68 Million	229,393 Added 24.99%	1,147,311 $32 Million
Q2 2020 Aug 04, 2020	SELL	$18.94 - $24.93 $15.2 Million - $20 Million	-803,192 Reduced 46.67%	917,918 $19.7 Million
Q1 2020 May 07, 2020	BUY	$16.68 - $32.25 $28.7 Million - $55.5 Million	1,721,110 New	1,721,110 $38.5 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.